Revance Therapeutics Vs. Pacira BioSciences Industry Stock Comparison

Sell

20

RVNC
Revance Therapeutics

Last Price:

5.82

Seasonality Move:

-5.59%

Sell

33

PCRX
Pacira BioSciences

Last Price:

14.50

Seasonality Move:

-2.82%

Sell

20

Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

The current Revance Therapeutics [RVNC] share price is $5.81. The Score for RVNC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

33

Pacira BioSciences (PCRX) is a Sell

Is Pacira BioSciences a Buy, Sell or Hold?

The current Pacira BioSciences [PCRX] share price is $14.52. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
PCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

The Revance Therapeutics share price today is $5.81
The current trend is moderately bearish and RVNC is experiencing slight selling pressure.

PCRX Stock Price Chart

What is Pacira BioSciences's stock price today?

The Pacira BioSciences share price today is $14.52
The current trend is relatively stagnant and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.

RVNC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.15	Buy
Relative Strength Index (14 RSI):	43.04	Sell
Chaikin Money Flow:	-820630	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(6.18 - 6.72)	Sell
Bollinger Bands (100):	(2.61 - 5.71)	Buy

PCRX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.66	Sell
Relative Strength Index (14 RSI):	46.94	Sell
Chaikin Money Flow:	-1701132	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.35 - 14.93)	Buy
Bollinger Bands (100):	(15.74 - 28.84)	Sell

RVNC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	6.16	Sell
20-day SMA:	6.41	Sell
50-day SMA:	5.27	Buy
200-day SMA:	5.03	Buy
8-day EMA:	6.08	Sell
20-day EMA:	6.14	Sell
50-day EMA:	5.45	Buy
200-day EMA:	6.57	Sell

PCRX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	13.81	Buy
20-day SMA:	14.24	Buy
50-day SMA:	16.6	Sell
200-day SMA:	26.16	Sell
8-day EMA:	14.17	Buy
20-day EMA:	14.41	Buy
50-day EMA:	16.86	Sell
200-day EMA:	24.76	Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.

Pacira BioSciences Earnings Growth & PCRX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.00 per share.

Revance Therapeutics Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pacira BioSciences Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):